Development of self-nanoemulsifying tablet (SNET) for bioavailability enhancement of sertraline

AUTOR(ES)

Rahman, Mohammad Akhlaquer, Mujahid, Mohammad

FONTE

Braz. J. Pharm. Sci.

DATA DE PUBLICAÇÃO

07/06/2018

RESUMO

Abstract The purpose of the study was to combine the advantages of self-nanoemulsifying drug delivery systems and tablets as a conventional dosage form. Self-nanoemulsifying drug delivery system (SNEDDS) was prepared to enhance the solubility and thus oral bioavailability of sertraline. Aqueous titration method was used to prepare the liquid SNEDDS; ternary phase diagrams were constructed and based on smaller droplet size (24.8 nm), minimum viscosity (153.63 cP) and polydispersity index (0.182), higher percentage transmittance (95%) and in vitro drug release (97%), an optimum system was designated. Liquid SNEDDS was transformed into free-flowing powder by solid adsorption technique followed by compression into tablets. In vitro release of sertraline from liquid and solid SNEDDS was found to be highly significant compared to plain sertraline (p<0.01). Pharmacokinetic studies after oral administration of liquid and solid SNEDDS in rats showed about 6-and 5-fold increased absorption of sertraline compared to the aqueous suspension of sertraline. These studies demonstrate that the solid SNEDDS are promising strategies for successful delivery of poorly water-soluble drug like sertraline.

Documentos Relacionados

• Extended Release Felodipine Self-Nanoemulsifying System
• Preparation and Evaluation of Self-nanoemulsifying Tablets of Carvedilol
• Optimization of self-nanoemulsifying formulations for weakly basic lipophilic drugs: role of acidification and experimental design
• Influence of sonication and in vitro evaluation of nifedipine self-nanoemulsifying drug delivery system
• Bioavailability of syrup and tablet formulations of cefetamet pivoxil.